Center for Adipocyte Structure and Function, Institute of Molecular Biology and Genetics, School of Biological Sciences, Seoul National University, Seoul, South Korea.
Nat Metab. 2023 May;5(5):735-759. doi: 10.1038/s42255-023-00786-y. Epub 2023 May 4.
Lipids are essential metabolites, which function as energy sources, structural components and signalling mediators. Most cells are able to convert carbohydrates into fatty acids, which are often converted into neutral lipids for storage in the form of lipid droplets. Accumulating evidence suggests that lipogenesis plays a crucial role not only in metabolic tissues for systemic energy homoeostasis but also in immune and nervous systems for their proliferation, differentiation and even pathophysiological roles. Thus, excessive or insufficient lipogenesis is closely associated with aberrations in lipid homoeostasis, potentially leading to pathological consequences, such as dyslipidaemia, diabetes, fatty liver, autoimmune diseases, neurodegenerative diseases and cancers. For systemic energy homoeostasis, multiple enzymes involved in lipogenesis are tightly controlled by transcriptional and post-translational modifications. In this Review, we discuss recent findings regarding the regulatory mechanisms, physiological roles and pathological importance of lipogenesis in multiple tissues such as adipose tissue and the liver, as well as the immune and nervous systems. Furthermore, we briefly introduce the therapeutic implications of lipogenesis modulation.
脂质是必需的代谢物,具有作为能量来源、结构成分和信号转导介质的功能。大多数细胞能够将碳水化合物转化为脂肪酸,这些脂肪酸通常被转化为中性脂质,以脂滴的形式储存。越来越多的证据表明,脂肪生成不仅在代谢组织中对于全身能量平衡至关重要,而且在免疫和神经系统中对于其增殖、分化甚至病理生理作用也至关重要。因此,脂肪生成过多或过少与脂质平衡的异常密切相关,可能导致病理后果,如血脂异常、糖尿病、脂肪肝、自身免疫性疾病、神经退行性疾病和癌症。对于全身能量平衡,脂肪生成涉及的多种酶受到转录和翻译后修饰的严格控制。在这篇综述中,我们讨论了脂肪生成在脂肪组织和肝脏等多种组织以及免疫和神经系统中的调节机制、生理作用和病理重要性的最新发现。此外,我们还简要介绍了脂肪生成调节的治疗意义。
Nat Metab. 2023-5
Semin Cell Dev Biol. 2020-12
Nutrients. 2018-9-29
Am J Physiol Gastrointest Liver Physiol. 2021-9-1
Metabolism. 2014-7
Eur J Clin Invest. 2018-9-26
Diabetes. 2016-7
World J Hepatol. 2025-8-27
MedComm (2020). 2025-7-25
Diabetol Metab Syndr. 2025-7-22
Cell Metab. 2022-11-1
Mol Cells. 2022-10-31
J Lipid Res. 2022-11